Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Centerpulse to Sell Vascutek to Terumo

By HospiMedica staff writers
Posted on 14 Oct 2002
As part of a continuing move to divest its cardiovascular interests, Centerpulse Ltd. More...
(Zurich, Switzerland) has agreed to sell its Vascutek vascular grafts business in Scotland to a Japanese medical device company, Terumo Corp. (Tokyo) for USD$170 million.

Vascutek makes and markets vascular prostheses and products that treat cardiovascular disease. The company has developed an international distribution network. Terumo manufactures and distributes a broad range of medical products, including cardiovascular implants, that are sold worldwide. The company is focused on growing its cardiovascular business and believes the acquisition of Vascutek is a strategic step toward that goal.

Centerpulse is divesting its cardiovascular businesses and refining its strategic focus to emphasize the core sectors of orthopedic, spine, and dental implants. In September, the
company announced the sale of IntraTherapeutics for USD$95 million.




Related Links:
Centerpulse
Terumo

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.